Showing results (501-510 of 572) with videos related to

Sort By:
Pageof 58
Proceedings of the National Academy of Sciences of the United States of America|May 23, 1995
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemiaT R Golub, G F Barker, S K Bohlander, et al.
The New England Journal of Medicine|September 27, 2013
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantationFrancisco M Marty, Drew J Winston, Scott D Rowley, et al.
The European Journal of Neuroscience|October 9, 2019
Exercise and microstructural changes in the motor cortex of older adultsChristopher D Rowley, Nicholas A Bock, Ralf Deichmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1992
Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocationsN R McCabe, R C Burnett, H J Gill, et al.
The Journal of Experimental Medicine|November 20, 2002
Silencing of B cell receptor signals in human naive B cellsNiklas Feldhahn, Ines Schwering, Sanggyu Lee, et al.
Blood|November 15, 1994
Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseasesH Kobayashi, K T Montgomery, S K Bohlander, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
Cytogenetic studies of 21 patients with acute lymphoblastic leukemia in relapseL M Secker-Walker, G Alimena, C D Bloomfield, et al.
Bone Marrow Transplantation|August 8, 2023
Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I studyJoseph P McGuirk, Leland Metheny, Luis Pineiro, et al.
Blood|January 7, 1998
Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6 ) is involved in only one halfY Sato, S K Bohlander, H Kobayashi, et al.
Blood|September 25, 1999
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipientsP J Martin, S D Rowley, C Anasetti, et al.
Pageof 58